Medicare Enrolled

Dr. Maria De La Pena, M.D

Student in an Organized Health Care Education/Training Program · Fort Lauderdale, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4800 NE 20TH TERRACE, Fort Lauderdale, FL 33308
3059745533
Registered in NPPES since 2008
NPI: 1245402635 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De La Pena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De La Pena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De La Pena

Dr. Maria De La Pena is a student in an organized health care education/training program specialist in Fort Lauderdale, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. De La Pena performed 7,207 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. De La Pena received a total of $18,671 from 47 pharmaceutical and/or device companies across 488 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De La Pena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 3% volume in FL $18,671 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 114029 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
7,207
Medicare services
Top 3% in FL for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,199 $0 $1
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,155 $1 $9
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,110 $97 $920
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
580 $64 $643
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
521 $98 $913
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
433 $71 $644
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
338 $61 $249
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
320 $174 $2,008
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
292 $136 $1,414
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
164 $153 $626
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
135 $242 $988
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
97 $0 $4
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
96 $104 $968
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
87 $94 $807
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
72 $62 $528
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
57 $27 $238
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
51 $210 $1,874
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
46 $213 $1,818
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $142 $1,280
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
39 $195 $795
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
38 $157 $1,346
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
34 $105 $908
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
31 $345 $2,993
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
30 $213 $1,731
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
30 $205 $1,650
Nerve destruction for spine-pelvis joint pain
A procedure that destroys the nerves supplying the joint between the spine and pelvis to relieve pain. Imaging guidance is used to ensure accurate placement.
30 $378 $3,377
New patient office visit, complex (60-74 min) 30 $174 $1,587
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
24 $341 $3,024
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $120 $1,123
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
20 $113 $880
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
20 $67 $601
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
20 $94 $843
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
16 $111 $852
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
15 $91 $795
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
13 $213 $1,906
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,671
Total received (2018-2024)
Avg $2,667/year across 7 years
Top 2% in FL for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
488
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,936
2023
$1,680
2022
$2,931
2021
$4,931
2020
$1,872
2019
$1,664
2018
$3,656

Payments by company (2024)

Abbott Laboratories
$496
Nevro Corp.
$336
Cerapedics Inc.
$273
SCILEX PHARMACEUTICALS INC.
$193
Forte Bio-Pharma LLC
$151
Boston Scientific Corporation
$142
Medtronic, Inc.
$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$95
Merz Pharmaceuticals, LLC
$76
Vertos Medical, Inc.
$33
IBSA Pharma Inc.
$21
SPR Therapeutics, Inc
$18
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$5,748
Spinal Simplicity, LLC
$1,920
Medtronic USA, Inc.
$1,644
Vertos Medical, Inc.
$1,266
Forte Bio-Pharma LLC
$1,237
Boston Scientific Corporation
$708
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$631
Scilex Pharmaceuticals Inc.
$617
Medtronic, Inc.
$609
SCILEX PHARMACEUTICALS INC.
$550
Nevro Corp.
$403
TELA Bio, Inc.
$311
Cerapedics Inc.
$273
Sentynl Therapeutics, Inc.
$269
Virtus Pharmaceuticals LLC
$227
BOSTON SCIENTIFIC CORPORATION
$203
SPR Therapeutics, Inc
$190
Collegium Pharmaceutical, Inc.
$179
NuVasive, Inc.
$167
Relievant Medsystems, Inc.
$130
Amniox Medical, Inc.
$129
Mallinckrodt Enterprises LLC
$125
RedHill Biopharma Inc.
$105
AngioDynamics, Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$99
PFIZER INC.
$96
SPINEFRONTIER, INC.
$94
BioDelivery Sciences International, Inc.
$87
Merz Pharmaceuticals, LLC
$76
INSYS Therapeutics Inc
$49
Interventional Pain Technologies Inc.
$47
Electronic Waveform Lab, Inc.
$46
IBSA Pharma Inc.
$41
Averitas Pharma Inc.
$40
Stimwave Technologies Incorporated
$39
The Institute of Musculoskeletal Science and Education
$23
Ferring Pharmaceuticals Inc.
$22
Bioventus LLC
$21
Hikma Pharmaceuticals USA
$21
Daiichi Sankyo Inc.
$20
Baxter Healthcare
$19
Horizon Therapeutics plc
$18
Nalu Medical, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$17
Amgen Inc.
$13
Shionogi Inc
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 49.9% of all-time payments
Associated products mentioned in payments ›
BELBUCA · BUNAVAIL 2.1 mg 30-count box · CATALYFT PL EXPANDABLE INTERBODY SYSTEM · CFNS StimQ Peripheral Nerve StimulatorSystem · Durolane · ETERNA · EUFLEXXA · EVENITY · GENERAL PAIN MANAGEMENT · General - Pain Management · HA MINUTEMAN G3-R · Hillrom - Volara System · I-FACTOR PEPTIDE ENHANCED BONE GRAFT · INTELLIS · Inspan · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LACTULOSE · LEVORPHANOL TARTRATE · LICART · LYRICA · Levorphanol · Levorphanol Tartrate · Morphabond ER · Movantik · NALOCET · NEOX · NURTEC ODT · Nalocet · Nalu Neurostimulation System · OFIRMEV · Omnia · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PACEL · PAXLOVID · PENNSAID · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Protege Family of SCS IPGs · QUTENZA · RELISTOR · SCS IPGs · SCS leads · SPRINT PNS System · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · Seglentis · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Superion · Superion Indirect Decompression System · Symproic · TLIF · Talicia · Tirosint · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xeomin · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a student in an organized health care education/training program specialist in Fort Lauderdale?
Compare student in an organized health care education/training programs in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs in nearby ZIP areas
3,086
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
HOLY CROSS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De La Pena is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. De La Pena experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. De La Pena performed 1,199 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. De La Pena receive payments from pharmaceutical companies?
Yes. Dr. De La Pena received a total of $18,671 from 47 companies across 488 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De La Pena's costs compare to other student in an organized health care education/training programs in Fort Lauderdale?
Dr. De La Pena's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De La Pena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →